Replies to post #8613 on Biostax Corp (BTAX)

[BuddyLou]

There are 2 paths in front of Cytocom at this moment:

1.)the more likely, they will be financed for the phase 2b/3a, file the s-1, get on the big board for about $5-7.

2.) Get bought out by big pharma at probably around $10-15 a share, and we all ching ching.

In reality, both could happen, Cytocom could get financed, trials start going good (which we know it will), and big pharma comes sweeping in to get LDN.

I do not think any IMUN shareholder doubts LDN or what it can do. We have seen the studies, the effectiveness. We are all believes of LDN, just not Noreen Griffen Wilson or the IMUN board.